Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roswitha M Wolfram

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Invasive Cardiology|August 1, 2006
Switching from Enoxaparin to Bivalirudin in Patients with Acute Coronary Syndromes without ST-segment Elevation who Undergo Percutaneous Coronary Intervention. Results from SWITCH--a multicenter clinical trialRon Waksman, Roswitha M Wolfram, Rebecca L Torguson, et al.
Radiology|January 31, 2004
Endovascular brachytherapy: effect on acute inflammatory response after percutaneous femoropopliteal arterial interventionsMartin Schillinger, Wolfgang Mlekusch, Roswitha M Wolfram, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 3, 2005
Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter studyBoris Pokrajac, Richard Pötter, Roswitha M Wolfram, et al.
The American Journal of Cardiology|March 28, 2006
Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary interventionRoswitha M Wolfram, Rebecca L Torguson, Salah-Eddine Hassani, et al.
Breast Cancer Research and Treatment|October 24, 2003
Defect of tumour necrosis factor-alpha (TNF-alpha) production and TNF-alpha-induced ICAM-1-expression in BRCA1 mutations carriersChristoph C Zielinski, Alexandra C Budinsky, Teresa M U Wagner, et al.
The American Journal of Cardiology|July 25, 2006
Procedural results and outcomes after extensive stent coverage with drug-eluting stent implantation in single coronary lesionsSundeep Mishra, Roswitha M Wolfram, Rebecca Torguson, et al.
The American Journal of Cardiology|April 26, 2006
Comparison of effectiveness and safety of drug-eluting stents versus vascular brachytherapy for saphenous vein graft in-stent restenosisSundeep Mishra, Roswitha M Wolfram, Rebecca Torguson, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 10, 2006
Percutaneous coronary intervention with drug-eluting stents in octogenarians: characteristics, clinical presentation, and outcomesSalah-Eddine Hassani, Roswitha M Wolfram, Pramod K Kuchulakanti, et al.
The Journal of Invasive Cardiology|June 6, 2006
Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patientsSalah-Eddine Hassani, William W Chu, Roswitha M Wolfram, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Invasive Cardiology|August 1, 2006
Switching from Enoxaparin to Bivalirudin in Patients with Acute Coronary Syndromes without ST-segment Elevation who Undergo Percutaneous Coronary Intervention. Results from SWITCH--a multicenter clinical trialRon Waksman, Roswitha M Wolfram, Rebecca L Torguson, et al.
Radiology|January 31, 2004
Endovascular brachytherapy: effect on acute inflammatory response after percutaneous femoropopliteal arterial interventionsMartin Schillinger, Wolfgang Mlekusch, Roswitha M Wolfram, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 3, 2005
Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter studyBoris Pokrajac, Richard Pötter, Roswitha M Wolfram, et al.
The American Journal of Cardiology|March 28, 2006
Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary interventionRoswitha M Wolfram, Rebecca L Torguson, Salah-Eddine Hassani, et al.
Breast Cancer Research and Treatment|October 24, 2003
Defect of tumour necrosis factor-alpha (TNF-alpha) production and TNF-alpha-induced ICAM-1-expression in BRCA1 mutations carriersChristoph C Zielinski, Alexandra C Budinsky, Teresa M U Wagner, et al.
The American Journal of Cardiology|July 25, 2006
Procedural results and outcomes after extensive stent coverage with drug-eluting stent implantation in single coronary lesionsSundeep Mishra, Roswitha M Wolfram, Rebecca Torguson, et al.
The American Journal of Cardiology|April 26, 2006
Comparison of effectiveness and safety of drug-eluting stents versus vascular brachytherapy for saphenous vein graft in-stent restenosisSundeep Mishra, Roswitha M Wolfram, Rebecca Torguson, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 10, 2006
Percutaneous coronary intervention with drug-eluting stents in octogenarians: characteristics, clinical presentation, and outcomesSalah-Eddine Hassani, Roswitha M Wolfram, Pramod K Kuchulakanti, et al.
The Journal of Invasive Cardiology|June 6, 2006
Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patientsSalah-Eddine Hassani, William W Chu, Roswitha M Wolfram, et al.
Pageof 2